Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 3 CAD 2.04%
Market Cap: 1.1B CAD
Have any thoughts about
Cronos Group Inc?
Write Note

P/E
Price to Earnings

-14.3
Current
-5.6
Median
22.3
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-14.3
=
Market Cap
1.1B CAD
/
Net Income
-57.4m USD
All Countries
Close
Market Cap P/E
CA
Cronos Group Inc
TSX:CRON
1.1B CAD -14.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY -5 347 888.9
US
Eli Lilly and Co
NYSE:LLY
788.1B USD 94.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 37.8
US
Johnson & Johnson
NYSE:JNJ
386.3B USD 26.3
US
Merck & Co Inc
NYSE:MRK
256.8B USD 18.7
CH
Roche Holding AG
SIX:ROG
217.8B CHF 18.9
UK
AstraZeneca PLC
LSE:AZN
170.7B GBP 34.2
CH
Novartis AG
SIX:NOVN
186B CHF 13.3
US
Pfizer Inc
NYSE:PFE
160.7B USD 37.8
Earnings Growth
CA
Cronos Group Inc
TSX:CRON
Average P/E: 35.2
Negative Multiple: -14.3
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
94.2
454%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
37.8
89%
US
Johnson & Johnson
NYSE:JNJ
26.3
-22%
US
Merck & Co Inc
NYSE:MRK
18.7
7 426%
CH
Roche Holding AG
SIX:ROG
18.9
30%
UK
AstraZeneca PLC
LSE:AZN
34.2
175%
CH
Novartis AG
SIX:NOVN
13.3
19%
US
Pfizer Inc
NYSE:PFE
37.8
712%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-14.6
2-Years Forward
P/E
-38.4
3-Years Forward
P/E
-126.6

See Also

Discover More